Art is Her Best Friend

Yvonne is living her dream. She is an artist, dedicated to raising awareness and funds for vision research.

Meet Molly Burke, FFB Youth Ambassador

Youth Ambassador

Molly Burke is a youth ambassador for the FFB, educating the public about living with blindness while delivering a message of hope to those living with vision impairment.

Meet Norma Bastidas, mom on a mission

Mom on a Mission

Norma is the second person in history to run 7 of the planet's most unforgiving environments on 7 continents in 1 year in support of vision research. Read her about incredible journey.

Meet Dale Turner, proof that research does work

Miracles do happen

Dale Turner is the first Canadian to receive an experimental treatment and have some sight restored by gene therapy. Dale is proof that investing in research works.

Tubedown-1 as a Modulator of Choroid-Retinal Angiogenesis

Robert L. Gendron, Ph.D. & Hélène Paradis
Basic Medical Sciences
Memorial University of Newfoundland, St. John's, Newfoundland and Labrador

The growth of abnormal blood vessels (angiogenesis) in the eye is a major contributing factor in vision loss and blindness in macular degeneration, diabetes and in premature infants. At this time, few effective treatments are available to halt or prevent uncontrolled retinal angiogenesis. Basic research into the mechanisms by which retinal blood vessels are regulated in health and disease may lead to new approaches for treating this condition.

Our laboratory studies the role of a novel factor called tubedown-1 which is present in the normal retina, but is suppressed in retinal angiogenesis contributing to blindness. Understanding the role tubedown-1 plays in retinal blood vessels may eventually help us to block abnormal blood vessel growth in the retina and could lead to new therapies for blinding eye diseases.

Privacy Policy